DMD and cancer: We present evidence that the role of DMD and dystrophin variants in cancer may be linked to a subset of signalling and adhesion‐related DAPC components, which cluster separately from the sarcoglycans, suggesting that DMD may influence tumour progression via signalling pathways rather than mechanical stability alone.